{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:04:58Z","timestamp":1761523498171},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2003,11,25]],"date-time":"2003-11-25T00:00:00Z","timestamp":1069718400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1038\/sj.bjc.6601407","type":"journal-article","created":{"date-parts":[[2003,11,25]],"date-time":"2003-11-25T20:37:00Z","timestamp":1069792620000},"page":"2155-2162","source":"Crossref","is-referenced-by-count":9,"title":["Induction of apoptosis in experimental human B cell lymphomas by conditional TRAIL-expressing T cells"],"prefix":"10.1038","volume":"89","author":[{"given":"E","family":"Ucur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Mattern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Wenger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Okouoyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Schroth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K-M","family":"Debatin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I","family":"Herr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2003,11,25]]},"reference":[{"key":"BF6601407_CR1","first-page":"2369","volume":"63","author":"S Armeanu","year":"2003","unstructured":"Armeanu S, Lauer UM, Smirnow I, Schenk M, Weiss TS, Gregor M, Bitzer M (2003) Adenoviral gene transfer of tumor necrosis factor-related apoptosis-inducing ligand overcomes an impaired response of hepatoma cells but causes severe apoptosis in primary human hepatocytes. Cancer Res 63: 2369\u20132372","journal-title":"Cancer Res"},{"key":"BF6601407_CR2","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1172\/JCI6926","volume":"104","author":"A Ashkenazi","year":"1999","unstructured":"Ashkenazi A, Pai RC, Fong S, Leung S, Lawrence DA, Marsters SA, Blackie C, Chang L, McMurtrey AE, Hebert A, DeForge L, Koumenis IL, Lewis D, Harris L, Bussiere J, Koeppen H, Shahrokh Z, Schwall RH (1999) Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest 104: 155\u2013162","journal-title":"J Clin Invest"},{"key":"BF6601407_CR3","first-page":"793","volume":"15","author":"B Bonavida","year":"1999","unstructured":"Bonavida B, Ng CP, Jazirehi A, Schiller G, Mizutani Y (1999) Selectivity of TRAIL-mediated apoptosis of cancer cells and synergy with drugs: the trail to non-toxic cancer therapeutics (review). Int J Oncol 15: 793\u2013802","journal-title":"Int J Oncol"},{"key":"BF6601407_CR4","doi-asserted-by":"crossref","first-page":"134","DOI":"10.4049\/jimmunol.160.1.134","volume":"160","author":"M Faris","year":"1998","unstructured":"Faris M, Kokot N, Latinis K, Kasibhatla S, Green DR, Koretzky GA, Nel A (1998) The c-Jun N-terminal kinase cascade plays a role in stress-induced apoptosis in Jurkat cells by up-regulating Fas ligand expression. J Immunol 160: 134\u2013144","journal-title":"J Immunol"},{"key":"BF6601407_CR5","doi-asserted-by":"publisher","first-page":"5865","DOI":"10.1038\/sj.onc.1204750","volume":"20","author":"S Fulda","year":"2001","unstructured":"Fulda S, Kuefer MU, Meyer E, van Valen F, Dockhorn-Dworniczak B, Debatin KM (2001) Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer. Oncogene 20: 5865\u20135877","journal-title":"Oncogene"},{"key":"BF6601407_CR6","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1038\/nm735","volume":"8","author":"S Fulda","year":"2002","unstructured":"Fulda S, Wick W, Weller M, Debatin KM (2002) Smac agonists sensitize for Apo2L\/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo. Nat Med 8: 808\u2013815","journal-title":"Nat Med"},{"key":"BF6601407_CR7","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1006\/mthe.2001.0439","volume":"4","author":"TS Griffith","year":"2001","unstructured":"Griffith TS, Broghammer EL (2001) Suppression of tumor growth following intralesional therapy with TRAIL recombinant adenovirus. Mol Ther 4: 257\u2013266","journal-title":"Mol Ther"},{"key":"BF6601407_CR8","first-page":"3112","volume":"63","author":"I Herr","year":"2003","unstructured":"Herr I, Ucur E, Herzer K, Okouoyo S, Ridder R, Krammer PH, von Knebel-Doeberitz M, Debatin K-M (2003) Glucocorticoid co-treatment induces apoptosis resistance towards cancer therapy in carcinomas. Cancer Res 63: 3112\u20133120","journal-title":"Cancer Res"},{"key":"BF6601407_CR9","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/75045","volume":"6","author":"M Jo","year":"2000","unstructured":"Jo M, Kim TH, Seol DW, Esplen JE, Dorko K, Billiar TR, Strom SC (2000) Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand. Nat Med 6: 564\u2013567","journal-title":"Nat Med"},{"key":"BF6601407_CR10","first-page":"3330","volume":"61","author":"S Kagawa","year":"2001","unstructured":"Kagawa S, He C, Gu J, Koch P, Rha SJ, Roth JA, Curley SA, Stephens LC, Fang B (2001) Antitumor activity and bystander effects of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene. Cancer Res 61: 3330\u20133338","journal-title":"Cancer Res"},{"key":"BF6601407_CR11","first-page":"734","volume":"59","author":"MM Keane","year":"1999","unstructured":"Keane MM, Ettenberg SA, Nau MM, Russell EK, Lipkowitz S (1999) Chemotherapy augments TRAIL-induced apoptosis in breast cell lines. Cancer Res 59: 734\u2013741","journal-title":"Cancer Res"},{"key":"BF6601407_CR12","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0014-5793(01)02816-2","volume":"505","author":"MR Kim","year":"2001","unstructured":"Kim MR, Lee JY, Park MT, Chun YJ, Jang YJ, Kang CM, Kim HS, Cho CK, Lee YS, Jeong HY, Lee SJ (2001) Ionizing radiation can overcome resistance to TRAIL in TRAIL-resistant cancer cells. FEBS Lett 505: 179\u2013184","journal-title":"FEBS Lett"},{"key":"BF6601407_CR13","first-page":"723","volume":"20","author":"T Kobayashi","year":"2002","unstructured":"Kobayashi T, Sawa H, Morikawa J, Ueno S, Katayama N, Zhang W, Shiku H (2002) Bax-induction alone is sufficient to activate apoptosis cascade in wild-type Bax-bearing K562 cells, and the initiation of apoptosis requires simultaneous caspase activation. Int J Oncol 20: 723\u2013728","journal-title":"Int J Oncol"},{"key":"BF6601407_CR14","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/86397","volume":"7","author":"D Lawrence","year":"2001","unstructured":"Lawrence D, Shahrokh Z, Marsters S, Achilles K, Shih D, Mounho B, Hillan K, Totpal K, DeForge L, Schow P, Hooley J, Sherwood S, Pai R, Leung S, Khan L, Gliniak B, Bussiere J, Smith CA, Strom SS, Kelley S, Fox JA, Thomas D, Ashkenazi A (2001) Differential hepatocyte toxicity of recombinant Apo2L\/TRAIL versions. Nat Med 7: 383\u2013385","journal-title":"Nat Med"},{"key":"BF6601407_CR15","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1128\/MCB.23.3.777-790.2003","volume":"23","author":"M Leverkus","year":"2003","unstructured":"Leverkus M, Sprick MR, Wachter T, Mengling T, Baumann B, Serfling E, Br\u00f6cker E-B, Goebeler M, Neumann M, Walczak H (2003) Proteasome inhibition results in TRAIL sensitization of primary keratinocytes by removing the resistance-mediating block of effector caspase maturation. Mol Cell Biol 23: 777\u2013790","journal-title":"Mol Cell Biol"},{"key":"BF6601407_CR16","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.4049\/jimmunol.171.3.1526","volume":"171","author":"JH Li","year":"2003","unstructured":"Li JH, Kirkiles-Smith NC, NcNiff JM, Pober JS (2003) TRAIL induces apoptosis and imflammatory gene expression in human endothelial cells. J Immunol 171: 1526\u20131533","journal-title":"J Immunol"},{"key":"BF6601407_CR17","doi-asserted-by":"crossref","unstructured":"Mohr A, Henderson G, Dudus L, Herr I, Debatin K-M, Weiher H, Fisher K, Zwacka RM (2003) AAV-encoded expression of TRAIL in experimental human colorectal cancer leads to tumor regression. Gene Therapy : in press","DOI":"10.1038\/sj.gt.3302154"},{"key":"BF6601407_CR18","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s00280-002-0465-z","volume":"50","author":"A Munshi","year":"2002","unstructured":"Munshi A, McDonnell TJ, Meyn RE (2002) Chemotherapeutic agents enhance TRAIL-induced apoptosis in prostate cancer cells. Cancer Chemother Pharmacol 50: 46\u201352","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF6601407_CR19","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1023\/A:1011336726649","volume":"6","author":"M Nagane","year":"2001","unstructured":"Nagane M, Huang HJ, Cavenee WK (2001) The potential of TRAIL for cancer chemotherapy. Apoptosis 6: 191\u2013197","journal-title":"Apoptosis"},{"key":"BF6601407_CR20","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1038\/sj.onc.1205151","volume":"21","author":"A Nesterov","year":"2002","unstructured":"Nesterov A, Ivashchenko Y, Kraft AS (2002) Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) triggers apoptosis in normal prostate epithelial cells. Oncogene 21: 1135\u20131140","journal-title":"Oncogene"},{"key":"BF6601407_CR21","doi-asserted-by":"publisher","first-page":"12687","DOI":"10.1074\/jbc.271.22.12687","volume":"271","author":"RM Pitti","year":"1996","unstructured":"Pitti RM, Marsters SA, Ruppert S, Donahue CJ, Moore A, Ashkenazi A (1996) Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem 271: 12687\u201312690","journal-title":"J Biol Chem"},{"key":"BF6601407_CR22","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/75007","volume":"6","author":"T Teitz","year":"2000","unstructured":"Teitz T, Wei T, Valentine MB, Vanin EF, Grenet J, Valentine VA, Behm FG, Look AT, Lahti JM, Kidd VJ (2000) Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MycN. Nat Med 6: 529\u2013535","journal-title":"Nat Med"},{"key":"BF6601407_CR23","doi-asserted-by":"publisher","first-page":"5386","DOI":"10.1093\/emboj\/16.17.5386","volume":"16","author":"H Walczak","year":"1997","unstructured":"Walczak H, Degli-Esposti MA, Johnson RS, Snolak PJ, Waugh JY, Boiani N, Timour MS, Gerhart MJ, Schooley KA, Smith CA, Goodwin RG, Rauch CT (1997) TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL. EMBO J 16: 5386\u20135397","journal-title":"EMBO J"},{"key":"BF6601407_CR24","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1006\/excr.2000.4840","volume":"256","author":"H Walczak","year":"2000","unstructured":"Walczak H, Krammer PH (2000) The CD95 (APO-1\/Fas) and the TRAIL (APO-2L) apoptosis systems. Exp Cell Res 256: 58\u201366","journal-title":"Exp Cell Res"},{"key":"BF6601407_CR25","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/5517","volume":"5","author":"H Walczak","year":"1999","unstructured":"Walczak H, Miller RE, Ariail K, Gliniak B, Griffith TS, Kubin M, Chin W, Jones J, Woodward A, Le T, Smith C, Smolak P, Goodwin RG, Rauch CT, Schuh JC, Lynch DH (1999) Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med 5: 157\u2013163","journal-title":"Nat Med"},{"key":"BF6601407_CR26","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/1074-7613(95)90057-8","volume":"3","author":"SR Wiley","year":"1995","unstructured":"Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, Sutherland GR, Davis T, Rauch C, Smith CA, Goodwin RG (1995) Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3: 673\u2013682","journal-title":"Immunity"},{"key":"BF6601407_CR27","first-page":"1","volume":"77","author":"P Workman","year":"1998","unstructured":"Workman P, Twentyman P, Balkwill F, Balmain A, Chaplin D, Double J, Embleton J, Newell D, Raymond R, S J, Stepens T, Wallace J (1998) United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) Guidelines for the welfare of animals in experimental neoplasia. Br J Cancer 77: 1\u201310","journal-title":"Br J Cancer"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6601407.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6601407","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6601407.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:53:55Z","timestamp":1684414435000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6601407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,11,25]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["BF6601407"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6601407","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,11,25]]}}}